These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34334299)

  • 1. Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope.
    Zheng C; Sleiman MM; Yang X; He S; Atkinson C; Tomlinson S
    J Heart Lung Transplant; 2021 Oct; 40(10):1112-1121. PubMed ID: 34334299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.
    Atkinson C; Qiao F; Yang X; Zhu P; Reaves N; Kulik L; Goddard M; Holers VM; Tomlinson S
    Circulation; 2015 Mar; 131(13):1171-80. PubMed ID: 25825397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement.
    Narang A; Qiao F; Atkinson C; Zhu H; Yang X; Kulik L; Holers VM; Tomlinson S
    J Neuroinflammation; 2017 Jun; 14(1):120. PubMed ID: 28629465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation.
    Zheng C; Ricci J; Zhang Q; Alawieh A; Yang X; Nadig S; He S; Engel P; Jin J; Atkinson C; Tomlinson S
    Front Immunol; 2021; 12():785229. PubMed ID: 34899752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury.
    Li C; Patel K; Tu Z; Yang X; Kulik L; Alawieh A; Allen P; Cheng Q; Wallace C; Kilkenny J; Kwon J; Gibney B; Cantu E; Sharma A; Pipkin M; Machuca T; Emtiazjoo A; Goddard M; Holers VM; Nadig S; Christie J; Tomlinson S; Atkinson C
    Am J Transplant; 2021 Jun; 21(6):2067-2078. PubMed ID: 33210808
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Lei B; Sleiman MM; Cheng Q; Tu Z; Zhu P; Goddard M; Martins PN; Langerude L; Nadig S; Tomlinson S; Atkinson C
    Front Immunol; 2021; 12():630581. PubMed ID: 34394069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-chain antibody construct with specificity of a natural IgM antibody reduces hepatic ischemia reperfusion injury in mice.
    Yang Z; Li C; Wang Y; Dong W; Yang M; Jin J
    J Cell Mol Med; 2024 Apr; 28(8):e18291. PubMed ID: 38597412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Imaging of Activated Complement in Ischemia-Reperfusion Injury Post-Cardiac Transplant.
    Sharif-Paghaleh E; Yap ML; Meader LL; Chuamsaamarkkee K; Kampmeier F; Badar A; Smith RA; Sacks S; Mullen GE
    Am J Transplant; 2015 Sep; 15(9):2483-90. PubMed ID: 25906673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural immunoglobulin M initiates an inflammatory response important for both hepatic ischemia reperfusion injury and regeneration in mice.
    Marshall K; Jin J; Atkinson C; Alawieh A; Qiao F; Lei B; Chavin KD; He S; Tomlinson S
    Hepatology; 2018 Feb; 67(2):721-735. PubMed ID: 28880403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia-reperfusion injury.
    Bongoni AK; Vikstrom IB; McRae JL; Salvaris EJ; Fisicaro N; Pearse MJ; Wymann S; Rowe T; Morelli AB; Hardy MP; Cowan PJ
    Sci Rep; 2021 Nov; 11(1):21873. PubMed ID: 34750424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation.
    Atkinson C; He S; Morris K; Qiao F; Casey S; Goddard M; Tomlinson S
    J Immunol; 2010 Dec; 185(11):7007-13. PubMed ID: 20962256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.
    Park P; Haas M; Cunningham PN; Alexander JJ; Bao L; Guthridge JM; Kraus DM; Holers VM; Quigg RJ
    J Am Soc Nephrol; 2001 Jul; 12(7):1383-1390. PubMed ID: 11423567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.
    Banda NK; Tomlinson S; Scheinman RI; Ho N; Ramirez JR; Mehta G; Wang G; Vu VP; Simberg D; Kulik L; Holers VM
    Front Immunol; 2020; 11():575154. PubMed ID: 33178202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived Growth Factor-B Protects Rat Cardiac Allografts From Ischemia-reperfusion Injury.
    Tuuminen R; Dashkevich A; Keränen MA; Raissadati A; Krebs R; Jokinen JJ; Arnaudova R; Rouvinen E; Ylä-Herttuala S; Nykänen AI; Lemström KB
    Transplantation; 2016 Feb; 100(2):303-13. PubMed ID: 26371596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
    Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
    Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts.
    Atkinson C; Floerchinger B; Qiao F; Casey S; Williamson T; Moseley E; Stoica S; Goddard M; Ge X; Tullius SG; Tomlinson S
    Circulation; 2013 Mar; 127(12):1290-9. PubMed ID: 23443736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.
    Hu C; Li L; Ding P; Li L; Ge X; Zheng L; Wang X; Wang J; Zhang W; Wang N; Gu H; Zhong F; Xu M; Rong R; Zhu T; Hu W
    J Immunol; 2018 Dec; 201(12):3717-3730. PubMed ID: 30429287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Inhibition Targeted to Injury Specific Neoepitopes Attenuates Atherogenesis in Mice.
    Dai S; Liu F; Ren M; Qin Z; Rout N; Yang XF; Wang H; Tomlinson S; Qin X
    Front Cardiovasc Med; 2021; 8():731315. PubMed ID: 34651027
    [No Abstract]   [Full Text] [Related]  

  • 19. Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury.
    Patel KJ; Cheng Q; Stephenson S; Allen DP; Li C; Kilkenny J; Finnegan R; Montalvo-Calero V; Esckilsen S; Vasu C; Goddard M; Nadig SN; Atkinson C
    Am J Respir Cell Mol Biol; 2019 Jun; 60(6):678-686. PubMed ID: 30571141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of murine P2Y11-like purinoreceptor protects against hypoxia/reoxygenation injury and decreases heart graft rejection lesions.
    Bourguignon T; Benoist L; Chadet S; Miquelestorena-Standley E; Fromont G; Ivanes F; Angoulvant D
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):780-790.e1. PubMed ID: 30711276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.